title: A pooled analysis of 20 post-authorization surveys of olmesartan involving 156,682 hypertensive patients.
authors.forename: Juergen
authors.initials: J
authors.lastname: Scholze
mesh_terms: D000368:Aged; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007093:Imidazoles / Q000009:adverse effects* / Q000627:therapeutic use*; D013777:Tetrazoles / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D007093:Imidazoles; D013777:Tetrazoles; C437965:olmesartan